GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins December 11, 2024
Displaying entries 22351 - 22400 of 40384 in total
PDB ID UniProt ID ▼ Title Descriptor
1P0M P06276 Crystal structure of human butyryl cholinesterase in complex with a choline molecule
1P0P P06276 Crystal structure of soman-aged human butyryl cholinesterase in complex with the substrate analog butyrylthiocholine
1P0Q P06276 Crystal structure of soman-aged human butyryl cholinesterase
1XLU P06276 X-Ray Structure Of Di-Isopropyl-Phosphoro-Fluoridate (Dfp) Inhibited Butyrylcholinesterase after Aging
1XLV P06276 Ethylphosphorylated Butyrylcholinesterase (Aged) Obtained By Reaction With Echothiophate
1XLW P06276 Diethylphosphorylated Butyrylcholinesterase (Nonaged) Obtained By Reaction With Echothiophate
2J4C P06276 Structure of human Butyrylcholinesterase in complex with 10mM HgCl2
2PM8 P06276 Crystal structure of recombinant full length human butyrylcholinesterase
2WID P06276 NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1
2WIF P06276 AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1
2WIG P06276 NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA4
2WIJ P06276 NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5
2WIK P06276 NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA6
2WIL P06276 AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5
2WSL P06276 Aged Form of Human Butyrylcholinesterase Inhibited by Tabun Analogue TA4
2XMB P06276 G117H mutant of human butyrylcholinesterase in complex with sulfate
2XMC P06276 G117H mutant of human butyrylcholinesterase in complex with fluoride anion
2XMD P06276 G117H mutant of human butyrylcholinesterase in complex with echothiophate
2XMG P06276 G117H mutant of human butyrylcholinesterase in complex with VX
2XQF P06276 X-ray Structure of human butyrylcholinesterase inhibited by racemic VX
2XQG P06276 X-ray Structure of human butyrylcholinesterase inhibited by racemic VR
2XQI P06276 X-ray Structure of human butyrylcholinesterase inhibited by racemic CVX
2XQJ P06276 X-ray Structure of human butyrylcholinesterase inhibited by pure enantiomer VX-(R)
2XQK P06276 X-ray Structure of human butyrylcholinesterase inhibited by pure enantiomer VX-(S)
2Y1K P06276 STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY CBDP (12H SOAK): PHOSPHOSERINE ADDUCT
3DJY P06276 Nonaged Form of Human Butyrylcholinesterase Inhibited by Tabun
3DKK P06276 Aged Form of Human Butyrylcholinesterase Inhibited by Tabun
4AQD P06276 Crystal structure of fully glycosylated human butyrylcholinesterase
4AXB P06276 Crystal structure of soman-aged human butyrylcholinesterase in complex with 2-PAM
4B0O P06276 Crystal structure of soman-aged human butyrylcholinesterase in complex with benzyl pyridinium-4-methyltrichloroacetimidate
4B0P P06276 Crystal structure of soman-aged human butyrylcholinesterase in complex with methyl 2-(pentafluorobenzyloxyimino)pyridinium
4BBZ P06276 Structure of human butyrylcholinesterase inhibited by CBDP (2-min soak): Cresyl-phosphoserine adduct
4BDS P06276 Human butyrylcholinesterase in complex with tacrine
4TPK P06276 Human butyrylcholinesterase in complex with N-((1-(2,3-dihydro-1H-inden-2-yl)piperidin-3-yl)methyl)-N-(2-methoxyethyl)-2-naphthamide
4XII P06276 X-ray structure of human butyrylcholinesterase in complex with N-((1-(2,3-dihydro-1H-inden-2-yl)piperidin-3-yl)methyl)-8-hydroxy-N-(2-methoxyethyl)-5-nitroquinoline-7-carboxamide Butyrylcholinesterase (E.C.3.1.1.8)
5DYT P06276 Crystal structure of human butyrylcholinesterase in complex with N-((1-benzylpiperidin-3-yl)methyl)-N-methylnaphthalene-2-sulfonamide
5DYW P06276 Crystal structure of human butyrylcholinesterase in complex with N-((1-benzylpiperidin-3-yl)methyl)-N-(2-methoxyethyl)naphthalene-2-sulfonamide
5DYY P06276 Crystal structure of human butyrylcholinesterase in complex with N-((1-benzylpiperidin-3-yl)methyl)naphthalene-2-sulfonamide
5K5E P06276 Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening
5LKR P06276 Human Butyrylcholinesterase complexed with N-Propargyliperidines
5NN0 P06276 Crystal structure of huBChE with N-((1-(2,3-dihydro-1H-inden-2-yl)piperidin-3-yl)methyl)-N-(2-(dimethylamino)ethyl)-2-naphthamide.
6F7Q P06276 Human Butyrylcholinesterase complexed with N-Propargyliperidines
6I0B P06276 Human butyrylcholinesterase in complex with the S enantiomer of a chlorotacrine-tryptophan multi-target inhibitor.
7QBQ P06276 Human butyrylcholinesterase in complex with (Z)-N-benzyl-1-(8-hydroxyquinolin-2-yl)methanimine oxide
7QBR P06276 Human butyrylcholinesterase in complex with (Z)-N-tert-butyl-1-(8-(3-(4-(prop-2-yn-1-yl)piperazin-1-yl)propoxy)quinolin-2-yl)methanimine oxide
7QHD P06276 Human Butyrylcholinesterase in complex with (S)-1-(4-((2-(1H-indol-3-yl)ethyl)carbamoyl)benzyl)-N-(3-((1,2,3,4-tetrahydroacridin-9-yl)amino)propyl)piperidine-3-carboxamide
7QHE P06276 Human Butyrylcholinesterase in complex with (S)-1-(4-((naphthalen-1-yl)carbamoyl)benzyl)-N-(3-((1,2,3,4-tetrahydroacridin-9-yl)amino)propyl)piperidine-3-carboxamide
7Q1M P06276 Crystal structure of human butyrylcholinesterase in complex with N-[(2S)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-2,2-diphenylacetamide
7Q1N P06276 Crystal structure of human butyrylcholinesterase in complex with N-[(2R)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-2,2-diphenylacetamide
7Q1O P06276 Crystal structure of human butyrylcholinesterase in complex with N-[(2S)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-3,3-diphenylpropanamide

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024